Specificity of therapeutic drug monitoring of tacrolimus in kidney transplant patients.
Sato
S
S
Department of Surgery III, Tokyo Women's Medical College, Japan.
Fuchinoue
S
S
Tojimbara
T
T
Fujita
S
S
Nakajima
I
I
Agishi
T
T
Hayashi
T
T
Teramura
Y
Y
Fujita
E
E
Iwasaki
K
K
D002851:Chromatography, High Pressure Liquid; D016903:Drug Monitoring / Q000379:methods; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D007124:Immunoenzyme Techniques; D007166:Immunosuppressive Agents / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D013058:Mass Spectrometry; D011184:Postoperative Period; D016559:Tacrolimus / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use; D013997:Time Factors
D007166:Immunosuppressive Agents; D016559:Tacrolimus